Drug Shortage Report for LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP
Report ID | 73298 |
Drug Identification Number | 01901958 |
Brand name | LIDOCAINE HYDROCHLORIDE 1% AND EPINEPHRINE 1:100 000 INJECTION USP |
Common or Proper name | LIDOCAINE HYDROCHLORIDE |
Company Name | PFIZER CANADA ULC |
Market Status | DORMANT |
Active Ingredient(s) | LIDOCAINE HYDROCHLORIDE EPINEPHRINE |
Strength(s) | 10MG 10MCG |
Dosage form(s) | SOLUTION |
Route of administration | BLOCK/INFILTRATION |
Packaging size | 25 x 20mL GVL MD |
ATC code | N01BB |
ATC description | ANESTHETICS, LOCAL |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-05-01 |
Actual start date | |
Estimated end date | |
Actual end date | 2019-03-25 |
Shortage status | Avoided shortage |
Updated date | 2019-03-26 |
Company comments | Item has been discontinued. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-01-22 | English | Compare |
v2 | 2019-01-22 | French | Compare |
v3 | 2019-03-26 | English | Compare |
v4 | 2019-03-26 | French | Compare |
Showing 1 to 4 of 4